NBIX Earnings Neurocrine Biosciences Inc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 1.91 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | 4.67 | 2026-02-11 | 10-K |
| Q3 2025 | 2025-09-30 | 3.19 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.13 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.08 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | 3.29 | 2026-02-11 | 10-K |
| Q3 2025 | 2024-09-30 | 2.29 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.04 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.42 | 2025-05-05 | 10-Q |
| FY 2025 | 2023-12-31 | 2.47 | 2026-02-11 | 10-K |
| Q3 2024 | 2023-09-30 | 1.01 | 2024-10-30 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.19 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.79 | 2024-05-01 | 10-Q |
| FY 2024 | 2022-12-31 | 1.56 | 2025-02-10 | 10-K |
| Q3 2023 | 2022-09-30 | 0.67 | 2023-10-31 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.03 | 2023-08-01 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.14 | 2023-05-03 | 10-Q |
| FY 2023 | 2021-12-31 | 0.92 | 2024-02-09 | 10-K |
| Q3 2022 | 2021-09-30 | 0.99 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.76 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.